Sign in

CIK 0001826457

  • Non-accelerated filer
  • Smaller reporting company
  • Emerging growth company

Monte Rosa Therapeutics, Inc.

Sign in to watch
Ticker
GLUE
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
Phone
+1 617-949-2643
Business address
321 HARRISON AVENUE, SUITE 900, BOSTON, MA, 02118
Former names
Monte Rosa Therapeutics, Inc.
  1. 4 Open-market buy 10% owner bought 1,050,000 shares at $19.00 ($19,950,000)
  2. 4 Open-market buy 10% owner bought 1,050,000 shares at $19.00 ($19,950,000)
  3. 4 Open-market buy 10% owner bought 1,050,000 shares at $19.00 ($19,950,000)
  4. 4 Open-market buy 10% owner bought 1,050,000 shares at $19.00 ($19,950,000)
  5. 4 Open-market buy 10% owner bought 1,050,000 shares at $19.00 ($19,950,000)
  6. 4 Open-market buy 10% owner bought 1,050,000 shares at $19.00 ($19,950,000)
  7. 4 Open-market buy 10% owner bought 1,050,000 shares at $19.00 ($19,950,000)
  8. 4 Open-market buy Director bought 1,050,000 shares at $19.00 ($19,950,000)
  9. 4 Open-market buy 10% owner bought 1,050,000 shares at $19.00 ($19,950,000)
  10. 4 Open-market buy 10% owner bought 1,050,000 shares at $19.00 ($19,950,000)
  11. 4 Open-market buy Director bought 157,895 shares at $19.00 ($3,000,005)
  12. 4 Open-market buy 10% owner bought 157,895 shares at $19.00 ($3,000,005)
  13. 4 Open-market buy Former 10% Owner bought 600,000 shares at $19.00 ($11,400,000)
  14. 4 Derivatives Options or other derivatives
  15. 4 Derivatives Options or other derivatives
  16. 4 Derivatives Options or other derivatives
  17. 4 Derivatives Options or other derivatives
  18. 4 Derivatives Options or other derivatives
  19. 4 Derivatives Options or other derivatives
  20. 4 Derivatives Options or other derivatives

Page 7 of 9 · 171 filings